Study of Telitacicept in Generalized Myasthenia Gravis

PHASE3CompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

March 28, 2023

Primary Completion Date

November 26, 2024

Study Completion Date

December 12, 2024

Conditions
Myasthenia Gravis, Generalized
Interventions
BIOLOGICAL

Telitacicept

Administered as an SC infusion

DRUG

Placebo

Administered as an SC infusion

Trial Locations (51)

Unknown

The First Affiliated Hospital of Bengbu Medical College, Bengbu

Anhui Provincial Hospital, Hefei

Beijing Hospital, Beijing

Xuanwu Hospital of Capital Medical University, Beijing

Fujian Medical University Union Hospital, Fuzhou

Lanzhou University Second Hospital, Lanzhou

The First Affiliated Hospital of Sun Yat-sen University, Guangzhou

Affiliated Hospital of Zunyi Medical University, Zunyi

The Second Hospital of Hebei Medical University, Shijiazhuang

The Second Affiliated Hospital of Harbin Medical University, Harbin

Nanyang First People's Hospital, Nanyang

Henan Provincial People's Hospital, Zhengzhou

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

Renmin Hospital of Wuhan University, Wuhan

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

Wuhan Hospital of Traditional Chinese and Western Medicine (Wuhan No.1 Hospital), Wuhan

Zhongnan Hospital of Wuhan University, Wuhan

Third Xiangya Hospital of Central South University, Changsha

Xiangya Hospital of Central South University, Changsha

Inner Mongolia Autonomous Region People's Hospital, Hohhot

Nanjing First Hospital, Nanjing

The First Affiliated Hospital of Soochow University, Suzhou

Jiangxi Provincial People's Hospital, Nanchang

China-Japan Union Hospital of Jilin University, Changchun

The First Hospital of Jilin University, Changchun

Dalian Municipal Central Hospital, Dalian

The First Affiliated Hospital of Dalian Medical University, Dalian

The Second Affiliated Hospital of Dalian Medical University, Dalian

The First Affiliated Hospital of Jinzhou Medical University, Jinzhou

Shengjing Hospital Affiliated to China Medical University, Shenyang

The First Hospital of China Medical University, Shenyang

The People's Hospital of Liaoning Province, Shenyang

The Second Affiliated Hospital of PLA Air Force Military Medical University, Xi'an

Xi'an Hi-tech Hospital, Xi'an

Xianyang Hospital of Yan'an University, Xianyang

Qilu Hospital of Shandong University, Jinan

Jining No.1 People's Hospital, Jining

Huashan Hospital Affiliated to Fudan University, Shanghai

Shanxi Bethune Hospital, Taiyuan

Shanxi Provincial People's Hospital, Taiyuan

The First Hospital of Shanxi Medical University, Taiyuan

West China Hospital, Sichuan University, Chengdu

Affiliated Hospital of North Sichuan Medical College, Nanchong

First Affiliated Hospital of Xinjiang Medical University, Ürümqi

The First Affiliated Hospital of Kunming Medical University, Kunming

The First People's Hospital of Yunnan Province, Kunming

The Second Affiliated Hospital of Kunming Medical University, Kunming

Sir Run Run Shaw Hospital, affiliated with to Zhejiang University College of Medicine, Hangzhou

Zhejiang Provincial People's Hospital, Hangzhou

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou

All Listed Sponsors
lead

RemeGen Co., Ltd.

INDUSTRY